Cargando…
Association of Dexmedetomidine With New-Onset Atrial Fibrillation in Patients With Critical Illness
IMPORTANCE: Dexmedetomidine is a widely used sedative in the intensive care unit (ICU) and has unique properties that may be associated with reduced occurrence of new-onset atrial fibrillation (NOAF). OBJECTIVE: To investigate whether the use of dexmedetomidine is associated with the incidence of NO...
Autores principales: | Song, Myung Jin, Jang, Yeonhoon, Lee, Ji Hyun, Yoon, Joo Heung, Kim, Dong Jung, Jung, Se Young, Lim, Sung Yoon |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Medical Association
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10130948/ https://www.ncbi.nlm.nih.gov/pubmed/37097632 http://dx.doi.org/10.1001/jamanetworkopen.2023.9955 |
Ejemplares similares
-
New-Onset Atrial Fibrillation in the Critically Ill*
por: Moss, Travis J., et al.
Publicado: (2017) -
New‐onset atrial fibrillation predicting for complicating cardiac adverse outcome in scrub typhus infection
por: Jang, Suk‐Yong, et al.
Publicado: (2019) -
Prognosis and management of new‐onset atrial fibrillation in critically ill patients
por: Qian, Jun, et al.
Publicado: (2021) -
Critical illness associated new onset atrial fibrillation: subsequent atrial fibrillation diagnoses and other adverse outcomes
por: Lancini, Daniel, et al.
Publicado: (2022) -
New-onset atrial fibrillation during critical illness: another piece of the puzzle
por: Seelig, Jaap, et al.
Publicado: (2022)